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 Abstract 
  The aim of this study was to validate the Japanese version of the Addenbrooke’s Cognitive Ex-
amination-Revised (ACE-R) [Mori:   Japanese Edition of Hodges JR’s Cognitive Assessment for Clini-
cians  , 2010] designed to detect dementia, and to compare its diagnostic accuracy with that of 
the Mini-Mental State Examination. The ACE-R was administered to 85 healthy individuals and 
126 patients with dementia. The reliability assessment revealed a strong correlation in both 
groups. The internal consistency was excellent (  -coefficient = 0.88). Correlation with the Clini-
cal Dementia Rating sum of boxes score was significant (r  s   = –0.61, p   !   0.001). The area under 
the curve was 0.98 for the ACE-R and 0.96 for the Mini-Mental State Examination. The cut-off 
score of 80 showed a sensitivity of 94% and a specificity of 94%. Like the original ACE-R and the 
versions designed for other languages, the Japanese version of the ACE-R is a reliable and valid 
test for the detection of dementia.    Copyright © 2012 S. Karger AG, Basel 
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 Introduction 
  The early diagnosis of dementia is of great importance for providing patients with the 
appropriate medical and social interventions. The Mini-Mental State Examination (MMSE), 
a widely used screening test for dementia   [2]  , can distinguish dementia patients from cogni-
tively healthy individuals and has achieved acceptable sensitivity and specificity in detecting 
dementia  [3, 4] . However, the MMSE has limitations in screening multiple cognitive domains 
and in detecting early dementia of disorders, such as frontotemporal dementia. The Adden-
brooke’s Cognitive Examination (ACE) was developed to be a brief test that is sensitive to 
indicators of the early stages of dementia and differentiates between dementia subtypes   [5]  . 
A revised version of the ACE (ACE-R)  [6]  provides a brief bedside cognitive assessment scale 
and has been reported to be useful for the early detection of dementia and for discerning 
Alz  heimer’s disease (AD) from frontotemporal dementia.
    The ACE-R examines key aspects of cognition and can be administered without special 
testing equipment or trained personnel   [6]  . This brief cognitive screening test incorporates 
elements of the MMSE, expanding the memory, language and visuospatial components and 
adding a verbal fluency component. The ACE-R involves five cognitive domains: attention/
orientation (18 points), memory (26 points), verbal fluency (14 points), language (26 points) 
and visuospatial components ability (16 points), adding up to a maximum total score of 100. 
Higher scores indicate higher levels of cognitive functioning. The ACE-R has been trans-
lated into several languages, and validation has been performed for the different versions of 
the ACE-R in several countries   [6–12]  . The aim of this study was to validate the reliability of 
the Japanese version of the ACE-R   [1]   for detecting dementia, to compare its diagnostic ac-
curacy with that of the MMSE and to investigate the performance of healthy individuals in 
the ACE-R total and subdomain scores.
  M e t h o d s  
  Adaptation of the ACE-R from English to Japanese 
  The ACE-R was translated into Japanese with cultural and linguistic adaptations, and 
the orientation/attention subtest is identical to that in the Japanese MMSE   [13]  . Three ques-
tions in the retrograde memory subtest were changed based on the same period of occur-
rence of the original ACE-R. The name of the current Prime Minister of the UK was replaced 
with that of the Prime Minister of Japan. The questions about a female prime minister of the 
UK and a US president who was assassinated were replaced by questions about the national 
singer of the Showa period (Hibari Misora) and the Japanese Prime Minister involved in the 
Lockheed bribery scandal (Kakuei Tanaka), respectively. In the verbal fluency subtest, the 
letter ‘p’ was replaced with the syllable ‘ka’ because the Japanese language is based on sylla-
bles rather than phonemes. We derived the scaled scoring systems for letter and category 
fluency based on the averages and standard deviations determined for the elderly Japanese 
population   [14]  . The words in the repetition subtest were selected according to the criteria 
used in the original English ACE-R: length, frequency and difficulty to articulate. In the 
naming subtest, six line-drawings of animals or objects that are less familiar to Japanese were 
replaced based on the familiarity rating for Snodgrass’s line-drawings   [15]  . The ‘kangaroo’, 
‘penguin’ and ‘crocodile’ drawings were replaced with ‘sea horse’, ‘owl’ and ‘peak’ drawings, 
respectively. The ‘harp’, ‘barrel’ and ‘crown’ drawings were replaced with ‘cigar’, ‘baby car-
riage’ and ‘helicopter’ drawings, respectively. In the comprehension subtest, the questions 
were changed in accordance with the replaced line-drawings. The reading subtest, which was 
designed to detect surface dyslexic reading errors, was adapted to maintain the irregularity 31
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of words similar to the original ACE-R. The Japanese language uses many compound Kanji 
words consisting of two or three Kanji characters, each with one or two syllables. In the sub-
test, however, we used two- or three-character stimuli, which do not abide by the reading 
rules and cannot be pronounced without semantics. [Japanese semantic dementia patients, 
whose reading disorders are surface dyslexic, usually pronounce Kanji words according to 
the regular rules. For example, they sometimes read 田舎 [i-na-ka] (rural) in our stimuli as 
田+舎 [ta-sha] (no meaning).] In the perceptual abilities subtest, four Katakana letters (Jap-
anese syllabograms) replaced English letters with similar geometric complexity. An alterna-
tive B version of the ACE-R had different name and address stimuli for the recall subtests to 
prevent recalling from the previous A version. We have published the Japanese version in a 
book as an appendix   [1]  .
  P a r t i c i p a n t s  
  This study received approval from the Research Ethics Committee of Tohoku Univer-
sity Hospital. All participants gave their informed consent to participate in this study and 
were treated according to the Declaration of Helsinki. The ACE-R was applied to a popula-
tion living in the prefecture of Miyagi (northeastern Japan) between June 2010 and March 
2011. All participants were between 50 and 90 years old, had normal or corrected-to-normal 
visual acuity and had no audition problems.
  Dementia  Group 
  We recruited 126 patients from the memory clinics of Tohoku University Hospital and 
the affiliated hospitals (Saito Hospital, Minami Tohoku Hospital and Miyagi Hospital). The 
subjects included 92 women and 34 men with a mean age of 77.3   8   7.6 years and a mean ed-
ucational achievement of 10.6   8   2.5 years. The clinical assessment included laboratory tests, 
neuropsychological assessment and structural neuroimaging (CT and/or MRI). We used the 
DSM-III R criteria for dementia   [16]   and the following criteria for specific diagnoses: the 
NINCDS-ADRDA for probable AD   [17]  , the frontotemporal lobar degeneration (FTLD) con-
sensus criteria   [18]  , the Consortium on Dementia with Lewy Bodies (DLB) criteria   [19]  , the 
MDS Task Force criteria for Parkinson’s disease with dementia  [20] , the NINDS-SPSP criteria 
for progressive supranuclear palsy (PSP)   [21]   and the Lang criteria for corticobasal degenera-
tion   [22]  . The severity of dementia was assessed using the Clinical Dementia Rating (CDR) 
  [23]  , and patients with very mild to moderate dementia were included. The clinical diagnoses 
were established independently of the participants’ performance on the ACE-R. The dementia 
group consisted of subjects diagnosed with AD (n = 79), DLB (n = 31), FTLD (n = 9), Parkin-
son’s disease with dementia (n = 3), PSP (n = 2) and corticobasal degeneration (n = 2).
  Healthy  Controls 
 We recruited 85 healthy subjects at the two centers for the welfare of the elderly program 
or among the patients’ spouses. We excluded patients who had a history of head injury, drug 
abuse, alcoholism or neurologic complaints. The control group included 51 women and 34 
men with a mean age of 71.5   8   9.1 years and a mean educational achievement of 12.3   8   2.6 
years.
    Procedures and Data Analysis 
  The normative data scores were divided into four age groups (50–64, 65–74, 75–79 and 
80–85 years) and described using one-way analysis of variance (ANOVA). Post-hoc pair-wise 
comparisons between the age ranges were assessed by using the Bonferroni correction. Mul-
tiple regression analyses were performed to assess the influence of age, education and sex on 
the participants’ performance in the total and subdomain ACE-R scores.32
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    The reliability of the scale was assessed by two methods: (1) the intraclass correlation 
coefficient (ICC) for the interrater test-retest reproducibility using alternative versions re-
peated after a mean interval of 2 months (the fixed order was version A followed by version 
B) in a subset of 13 dementia patients and 19 healthy controls, and (2) Cronbach’s alpha co-
efficient for the internal consistency. The concurrent validity was assessed using the Spear-
man rho correlation between the ACE-R and the CDR sum of boxes (CDR-SOB) score in the 
dementia group.
    The demographic data and the ACE-R total, subdomain and MMSE (ACE-R) scores of 
the dementia and control groups were compared using one-way ANOVA. The diagnostic ac-
curacy was assessed by receiver operating characteristic (ROC) analysis, which permits the 
calculation of the overall test performance by considering the sensitivity/specificity pairs for 
every possible threshold of a test. The resulting ROC curve can be used for the estimation of 
the optimal cutoff according to the costs of the false-positive and false-negative results. In 
the present study, the optimal cutoff was defined as the point on the ROC curve where the 
product of the corresponding sensitivity/specificity pair reached the maximum value. The 
area under the ROC curve was used as an indicator of test performance and was calculated 
using nonparametric methods. All of the statistical analyses were performed using SPSS ver-
sion 1.9 (IBM SPSS Inc.). The level of statistical significance was set at p   !   0.05.
  R e s u l t s  
  The administration of the Japanese version of the ACE-R required 28.8   8   10.5 min 
(range 15–63) for the dementia group and 17.0  8  3.6 min (range 12–30) for the control group.
  Normative  Data 
    Table 1   summarizes the age-specific performance of the healthy controls, who were di-
vided into four age groups, in the total ACE-R and the subdomains.
    ANOVA revealed a significant effect of age on the total score (F = 5.68, p   !   0.01), mem-
ory (F = 5.60, p   !   0.01) and language (F = 2.86, p = 0.04). The subjects of the 75–79 and 80–
85 age ranges had significantly lower ACE-R total, memory and language scores compared 
to those of the 50–64 age group. Younger individuals had higher ACE-R total, memory and 
verbal fluency scores than older individuals in the control group.
    In the multiple linear regression analysis, the ACE-R total score or the subdomain 
scores were entered into the multiple regression model together with possible confounds 
that included age, education level and sex. There were significant effects of age on the ACE-
R total score (partial r = –0.28, p = 0.01) and memory subscales (partial r = –0.29, p = 0.01), 
of education on the ACE-R total score (partial r = 0.31, p  !   0.01), memory subscale (partial 
Table 1. N  ormative data for the total ACE-R score and subscores for Japanese subjects according to age group (mean 8 SD)
Age group Patients
n
Education
years
Total ACE-R
score
Attention/
orientation
subscore
Memory
subscore
Fluency
subscore
Language
subscore
Visuospatial
subscore
50–64 years 22 13.782.9 95.385.2 17.980.3 23.483.2 13.381.7 24.982.1 15.880.5
65–74 years 19 12.082.3 91.188.4 17.581.2 21.084.8 12.382.0 24.381.7 15.980.2
75–79 years 31 12.282.0 88.586.7 17.480.8 19.884.1 12.181.9 23.481.9 15.880.5
80–85 years 13 10.482.3 88.083.4 17.880.4 18.482.9 11.782.5 24.381.5 15.880.433
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r = 0.30, p = 0.01) and language subscale (partial r = 0.26, p = 0.02), and of sex on the ACE-
R total score (partial r = 0.28, p = 0.01) and verbal fluency subscale (partial r = 0.29, p = 
0.01).
  Reliability  and  Validity 
  The mean interval between the test and retest was 60   8   17.3 days. The ICC was strong 
(r = 0.77) for healthy controls and very strong (r = 0.90) for patients with dementia. Cronbach’s 
alpha coefficient for the ACE-R was 0.88, indicating an excellent internal consistency. There 
was a considerably high correlation between the ACE-R total score and the CDR-SOB score 
in the dementia group (r  s   = –0.61, two-tailed, p   !   0.01)  ( fig. 1 ).
  D i a g n o s t i c   A c c u r a c y  
  The results of one-way ANOVA showed the statistical differences in age (F = 24.6, p   !  
0.01), education level (F = 22.0, p   !   0.01) and sex (F = 3.9, p = 0.05) between the healthy con-
trols and the patients. A similar set of analyses confirmed significant group effects on the 
mean scores of the ACE-R total, subdomains and MMSE (ACE-R) (  table 2  ).
    The difference in ACE-R total score between the healthy controls and the dementia 
group was statistically significant (F = 295.5, p   !   0.01). Significant group differences were 
also found in orientation/attention (F = 158.7, p   !   0.01), memory (F = 490.0, p   !   0.01), verbal 
fluency (F = 142.3, p   !   0.01), language (F = 89.0, p   !   0.01), visuospatial (F = 63.8, p   !   0.01) 
and MMSE scores (F = 208.1, p   !   0.01). Given the significant differences caused by age, edu-
cation and sex, these variables were included as covariates in an analysis of covariance (AN-
COVA) between the healthy controls and the dementia patients. ANCOVA showed a highly 
significant difference between groups for the ACE-R total (F = 233.9, p   !   0.01), subdomains 
[orientation/attention (F = 131.2, p   !   0.01), memory (F = 390.9, p   !   0.01), verbal fluency (F = 
103.5, p  !  0.01), language (F = 62.7, p  !  0.01) and visuospatial (F = 61.0, p  !  0.01)] and MMSE 
(ACE-R) (F = 170.6, p   !   0.01).
    The significant differences due to age, education and sex were confirmed by ANOVA 
(  table 2  ) and ANCOVA with years of education as the covariate (p   !   0.05). The patients 
were matched one to one to the healthy controls on the basis of age (within 2 years), educa-
tion level (within 1 year) and sex. Of the 85 healthy controls, 49 (mean age 74.9  8  7.1 years, 
range 52–85; mean education 11.7   8   1.9 years, range 8–17) were matched with subjects 
  Fig. 1.   Scatterplot of ACE-R total scores indicates 
the dementia severity. 34
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from the dementia group (mean age 75.1   8   7.0 years, range 52–85; mean education 11.6 
  8   1.8 years, range 8–16). The patient subgroups included AD (n = 35), DLB (n = 9), FTLD 
(n = 4) and PSP (n = 1). Separate one-way ANOVA tests showed no significant differences 
according to age (F = 0.03, p = 0.88) or education (F = 0.05, p = 0.83). However, ANOVA 
revealed significant effects of the ACE-R total (F = 129.54, p   !   0.01), orientation/attention 
(F = 63.39, p   !   0.01), memory (F = 198.01, p   !   0.01), verbal fluency (F = 57.87, p   !   0.01), 
language (F = 31.55, p   !   0.01), visuospatial (F = 31.09, p   !   0.01) and MMSE (ACE-R) (F = 
95.73, p   !   0.01).
  Two ROC curves were estimated from the scores of the ACE-R and the MMSE (ACE-R), 
which are presented in   figure 2  .
    The area under the curve (AUC) was 0.98 for the ACE-R and 0.96 for the MMSE. Al-
though the AUC for the ACE-R was slightly superior to that for the MMSE, this difference 
was not statistically significant. The optimal cut-off point of the ACE-R was 80, which yield-
ed a score of 94% for both sensitivity and specificity (  table 3  ).
  After adjusting for the differences in age, education and sex, the analysis of the diagnos-
tic accuracy was repeated on the case-controlled samples. The AUC values (ACE-R 0.97 and 
MMSE 0.94) and the optimal cut-off point of the ACE-R were similar (94% for sensitivity and 
92% for specificity) to the values determined in the original sample.
Table 2. D  emographic data and neuropsychological test scores (mean 8 SD)
Original sample C  ase-controlled sample
controls
(n = 85)
dementia
(n = 126)
p controls
(n = 49)
dementia
(n = 49)
p
Male/female 34/51 34/92 <0.005 16/33 16/33 1
Age, years 71.589.1 77.387.6 <0.01 74.987.1 75.187.0 0.88
Education, years 12.382.6 10.682.5 <0.01 11.781.9 11.681.8 0.83
MMSE score (max. 30) 28.681.4 21.184.7 <0.01 28.581.3 22.184.3 <0.01
Total ACE-R score (max. 100) 90.886.9 58.4816.4 <0.01 89.586.2 62.5815.4 <0.01
Orientation/attention (max. 18) 17.680.8 12.983.4 <0.01 17.680.7 13.783.3 <0.01
Memory (max. 26) 20.884.2 7.484.4 <0.01 20.083.9 7.984.5 <0.01
Verbal fluency (max. 14) 12.482.0 7.183.8 <0.01 12.182.1 7.783.5 <0.01
Language (max. 26) 24.181.9 18.485.4 <0.01 23.981.8 19.685.1 <0.01
Visuospatial (max. 16) 15.880.5 12.783.6 <0.01 15.880.5 13.582.8 <0.01
ACE-R MMSE
Cut-off score 80 25
Sensitivity* 0.94/0.94 0.98/0.98
Specificity* 0.94/0.92 0.87/0.80
AUC* 0.98/0.97 0.96/0.94
*   Original sample/case-controlled sample.
Table 3. O  ptimal cut-off scores 
for screening tests35
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  Discussion 
  The present study demonstrates that the Japanese version of the ACE-R has a high test-
retest reliability, a satisfactory level of internal consistency, a good correlation with the CDR-
SOB and a high diagnostic accuracy. These findings confirm that the Japanese version of the 
ACE-R is a reliable and valid tool for the assessment of dementia. This test can be adminis-
tered in a short time period, similar to other versions of the ACE-R that have been adapted 
to different languages   [6–9, 11]  .
    In this study, the reliability was tested according to the test-retest reliability, interrater 
reliability and internal consistency. Even though the test-retest was performed by different 
raters using alternative versions, which is the harshest condition, the reliability of the Japanese 
ACE-R was satisfactory for both the dementia and healthy control groups; the ICCs were 0.90 
for the former and 0.77 for the latter. The reason for the discrepancy between the groups is 
that the healthy controls achieved high scores with a small variance among individuals. Un-
fortunately, comparisons cannot be made because the test-retest reliability has not been ex-
amined in previous studies. Cronbach’s alpha coefficient was 0.88 in a combined analysis of 
the dementia and control groups. This result is consistent with previous studies   [6, 8, 10, 11]  .
    In the present study, the ACE-R total scores showed a moderate correlation with the 
CDR-SOB scores, which indicates that the Japanese version of the ACE-R is a valid tool for 
assessing the severity of dementia. A similar moderate correlation between the ACE-R total 
scores and the CDR-SOB scores was demonstrated in a previous study   [10]  .
    The diagnostic accuracy of the Japanese ACE-R for dementia was excellent, which is 
comparable with the results from previous studies of different language versions  [7, 11] . Com-
pared to the MMSE, the ACE-R covers a wider range of cognitive domains, such as semantic, 
visuoperceptual and executive functions. Consequently, the ACE-R offers the advantage of 
exploring different patterns of cognitive deterioration and, thus, may be suitable for the de-
tection of non-memory-type dementias. The optimal cut-off score of the Japanese ACE-R 
was similar to the cut-off scores calculated in previous studies   [6, 9–12]  . Although the sensi-
tivity and specificity of the ACE-R for detecting dementia were not significantly higher com-
pared to those obtained in the MMSE, the sensitivity may be high for FTLD, DLB and other 
types of dementia for which memory is relatively preserved. Moreover, this feature of the 
ACE-R may provide a significant clue to the differential diagnosis of the cause of dementia, 
as the performance profiles for the ACE-R domains differ among the causes. The ACE-R has 
  Fig. 2.  ROC curve of the MMSE and ACE-R as tests 
for detecting dementia. Diagonal segments are pro-
duced by ties. 36
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been reported to have a good discrimination property between AD and FTLD  [6, 9, 10] . Fur-
ther studies are necessary to investigate the possibility that the ACE-R discriminates differ-
ent causes of dementia.
    Previous studies have shown significant effects of sex   [7]  , age   [6, 8]   and education   [7, 8, 
24]   on the ACE-R total score, which is comparable with our study. When interpreting the 
ACE-R total score, these factors should be taken into consideration.
    In conclusion, the present study demonstrates that the Japanese version of the ACE-R is 
a useful tool for the accurate detection of early stages of dementia in healthy elderly indi-
viduals. The test yields comparable scores among different language versions, which is ad-
vantageous for its use in international studies. Future research efforts are required to provide 
evidence for the discriminatory usefulness of the Japanese ACE-R across the various types 
of dementia.
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